James I. Merlino Will Lead The Joint Commission
The current chief operating officer will take over the organization on January 1, 2027.
Updated on Sept. 23, 2026 in People
Live Poll
Do you trust that national accrediting bodies effectively ensure high-quality care in your local hospitals?
The Joint Commission has announced that James I. Merlino will succeed Jonathan B. Perlin as president and CEO on January 1, 2027. Perlin will transition into the role of strategic advisor and president emeritus on that date.
Why it matters
The leadership change aims to accelerate the organization's current strategy to modernize accreditation processes and reduce administrative burdens for healthcare providers. The Board of Commissioners selected Merlino for his operational expertise and commitment to patient-centered care.
The Joint Commission evaluates 23,000 healthcare organizations across its 75-year history. The incoming CEO brings three decades of executive experience to the role.
The players
Jonathan B. Perlin
He is the seventh president and CEO in the 75-year history of the Joint Commission.
James I. Merlino
He is the current chief operating officer of the Joint Commission who previously worked at the Cleveland Clinic and Press Ganey.
The Joint Commission
It is an organization headquartered in Oakbrook Terrace, Illinois, that evaluates more than 23,000 healthcare entities.
The details
Following a rigorous selection process, the Board of Commissioners appointed Merlino, who currently serves as the chief operating officer. He previously held leadership positions at the Cleveland Clinic and Press Ganey before joining the organization.
Timeline
The Joint Commission was founded in 1951.
Jonathan B. Perlin retires from his role on December 31, 2026.
James I. Merlino begins his term as president and CEO on January 1, 2027.
Market Landscape
This leadership transition marks the latest evolution in the organization's adherence to the standards and goals established by the Joint Commission's 1951 founding charter. It positions the firm to maintain its status as a primary arbiter of safety standards within the competitive healthcare accreditation sector.
Healthcare providers should anticipate a continued focus on modernization and administrative burden reduction as the new leadership takes effect in 2027. These changes are designed to streamline accreditation compliance for the 23,000 organizations currently served.
The takeaway
The transition ensures institutional continuity while signaling a shift toward more modernized, operationally focused healthcare oversight. Stakeholders should monitor the organization for upcoming updates to accreditation requirements as the new CEO settles into the role.
Further reading
For more on industry leadership changes, visit People.
Live Poll
Do you trust that national accrediting bodies effectively ensure high-quality care in your local hospitals?
